Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)

    Supports investigator-initiated, milestone-driven clinical trials requiring enhanced oversight for up to 7 years, with mechanistic studies as applicable and one trial per application.

    OverviewSimilar Grants
    OverviewSimilar Grants

    NIAMS Clinical Trial Implementation Cooperative Agreement

    This grant supports investigator-initiated clinical trials in arthritis, musculoskeletal, or skin diseases, funding both trial preparation and implementation for studies ready to begin.

    HHS-NIH11Forecasted Jul 2, 2027Forecasted

    Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)

    NIH plans a milestone-driven award supporting planning and early to definitive clinical trials across biomedical and other interventions for up to 7 years; applications are not yet being accepted.

    HHS-NIH11Forecasted Jul 31, 2027Forecasted

    Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required)

    Renewal opportunity for ongoing NINDS-supported clinical trials needing more time and resources via U01 cooperative agreements.

    HHS-NIH11Due Mar 5, 2027

    Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)

    NIH will fund investigator-initiated multi-site or decentralized clinical trials relevant to its mission, supporting planning and implementation over up to 7 years using a milestone-driven UG3/UH3 grant mechanism.

    HHS-NIH11Forecasted Feb 16, 2027Forecasted

    Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)

    NHLBI plans to fund single-site clinical trials (R61/R33) testing therapeutic, behavioral, or prevention strategies, encouraging innovative designs.

    HHS-NIH11Due Feb 1, 2027